TY - JOUR
T1 - Von Hippel-Lindau disease
AU - Couch, Vicki
AU - Lindor, Noralane M.
AU - Karnes, Pamela S.
AU - Michels, Virginia V.
PY - 2000
Y1 - 2000
N2 - An autosomal dominant tumor predisposition syndrome, von HippeI-Lindau disease (VHL) is characterized by the presence of benign and malignant tumors. Hallmark lesions include retinal angiomas, hemangioblastomas of the cerebellum and spinal cord, and renal cell carcinomas. Affected persons may also have angiomatous or cystic lesions of the kidneys, pancreas, and epididymis, as well as adrenal pheochromocytomas. In this article, we discuss the clinical features and diagnostic criteria for this clinically underdiagnosed condition. An update on recent findings regarding the molecular genetics of VHL is provided, including a discussion of the evolving understanding of genotype-phenotype correlations. Understanding the molecular and functional aspects of this condition will lead to the development of strategies for the management and treatment of inherited and sporadic VHL- associated tumors.
AB - An autosomal dominant tumor predisposition syndrome, von HippeI-Lindau disease (VHL) is characterized by the presence of benign and malignant tumors. Hallmark lesions include retinal angiomas, hemangioblastomas of the cerebellum and spinal cord, and renal cell carcinomas. Affected persons may also have angiomatous or cystic lesions of the kidneys, pancreas, and epididymis, as well as adrenal pheochromocytomas. In this article, we discuss the clinical features and diagnostic criteria for this clinically underdiagnosed condition. An update on recent findings regarding the molecular genetics of VHL is provided, including a discussion of the evolving understanding of genotype-phenotype correlations. Understanding the molecular and functional aspects of this condition will lead to the development of strategies for the management and treatment of inherited and sporadic VHL- associated tumors.
UR - http://www.scopus.com/inward/record.url?scp=0034095068&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034095068&partnerID=8YFLogxK
U2 - 10.4065/75.3.265
DO - 10.4065/75.3.265
M3 - Review article
C2 - 10725953
AN - SCOPUS:0034095068
SN - 0025-6196
VL - 75
SP - 265
EP - 272
JO - Mayo Clinic Proceedings
JF - Mayo Clinic Proceedings
IS - 3
ER -